Skip to content


Review of the Surveillance and Epidemiology of Drug-resistant Infections Consortium (SEDRIC)

We conducted a review of the Wellcome Trust's Surveillance and Epidemiology of Drug-resistant Infections Consortium (SEDRIC)


The Surveillance and Epidemiology of Drug-resistant Infections Consortium (SEDRIC) was established in January 2018 with the support of the Wellcome Trust. With a core objective of identifying critical gaps in effective surveillance, SEDRIC aims to enhance global efforts in combatting this urgent public health challenge.

SEDRIC serves as a global think-tank, bringing together a diverse group of international experts dedicated to transforming the way countries track, share, and analyse information related to the emergence and spread of drug-resistant infections.

We conducted a comprehensive short-term review of SEDRIC’s progress, impact, and current working model.

Our role

After providing support to develop SEDRIC’s Theory of Change in 2020, a small team of Itad evaluators assessed SEDRIC’s achievements in strengthening drug-resistant infection surveillance and epidemiology.

The review provided insights into SEDRIC’s effectiveness, highlighting areas of success, and identifying opportunities for improvement in order to maximise its contributions to global health.

Methods and approaches

The project undertook several activities to evaluate the progress and impact of SEDRIC, as well as review its current working model. These activities included:

  • Document Review: We conducted a thorough examination of SEDRIC’s foundational documents, such as its mission statement, strategic plans, and previous evaluation reports. This analysis aims to generated a comprehensive understanding of SEDRIC’s initial goals and the ability to track its progress towards achieving them.


  • Stakeholder Engagement: We gathered perspectives and insights from key stakeholders involved in SEDRIC’s activities, including SEDRIC board and SEDRIC members, policymakers, healthcare professionals, researchers. Collection methods included interviews, surveys, and focus group discussions, ensuring a comprehensive assessment of SEDRIC’s achievements and effectiveness.


  • Progress Assessment: The project team evaluated SEDRIC’s accomplishments against its defined objectives and milestones. This assessment involved analysing SEDRIC’s contributions to bridging critical gaps in drug-resistant infection surveillance, facilitating information sharing, and fostering international collaboration.


  • Outcome Evaluation: The project team applied qualitative methods to assess the tangible and intangible impacts generated by SEDRIC’s work. Our evaluation considered the influence of SEDRIC’s efforts on policy development, research advancements, capacity building, and the adoption of innovative surveillance approaches worldwide.


  • Working Model Review: The review critically analysed SEDRIC’s current working model, including its governance structure, coordination mechanisms, communication channels, and resource allocation strategies. The assessment provided recommendations for optimising SEDRIC’s operations, enhancing its efficiency, and ensuring the achievement of its core objectives.

Outcomes and impact

The primary deliverable of this project is a comprehensive review report. The report presented a detailed analysis of SEDRIC’s progress and impact, highlighting successes, challenges, and areas for improvement.

Our report provides evidence-based recommendations to guide SEDRIC’s future strategies, enabling it to fulfil its role as a leading global think-tank in drug-resistant infection surveillance and epidemiology.